PATHOLOGY OF THE UTERINE CERVIX SUMALEE SIRIAUNGKUL, M.D. DEPARTMENT OF PATHOLOGY

Similar documents
Colposcopy. Attila L Major, MD, PhD

Cervical Cancer : Pap smear

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Histopathology: Cervical HPV and neoplasia

Understanding Your Pap Test Results

Becoming a colposcopist: Colposcope case studies

Cervical Dysplasia and HPV

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

Done by khozama jehad. Neoplasia of the cervix

Human Papillomavirus

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

Clinically Microscopically Pathogenesis: autoimmune not lifetime

EU guidelines for reporting gynaecological cytology

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

Cervical Conization. 1

What is cervical cancer?

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Biomed Environ Sci, 2015; 28(1): 80-84

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

Making Sense of Cervical Cancer Screening

Cervical Cancer Screening. David Quinlan December 2013

The society for lower genital tract disorders since 1964.

I have no financial interests in any product I will discuss today.

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

CINtec p16 INK4a Staining Atlas

Gisela Dallenbach-Hellweg Magnus von Knebel Doeberitz Marcus J.Trunk Color Atlas of Histopathology of the Cervix Uteri

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

I have no financial interests in any product I will discuss today.

I have no financial interests in any product I will discuss today.

Management of Abnormal Cervical Cytology and Histology

When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?

In situ and Invasive Endocervical Carcinoma: Problems and Pitfalls in Diagnosis

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Cervical Precancer: Evaluation and Management

Chapter 10: Pap Test Results

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

News. Laboratory NEW GUIDELINES DEMONSTRATE GREATER ROLE FOR HPV TESTING IN CERVICAL CANCER SCREENING TIMOTHY UPHOFF, PHD, DABMG, MLS (ASCP) CM

Clinical Practice Guidelines June 2013

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre

chapter 4. The effect of oncogenic HPV on transformation zone epithelium

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

Cytology Report Format

Eradicating Mortality from Cervical Cancer

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

Performance of the Aptima High-Risk Human Papillomavirus mrna Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

Diseases of the vulva

Page # 1. Endometrium. Cellular Components. Anatomical Regions. Management of SIL Thomas C. Wright, Jr. Most common diseases:

The ABCs of TBS. A Novice's Guide to the Bethesda System

Focus. International #52. HPV infection in High-risk HPV and cervical cancer. HPV: Clinical aspects. Natural history of HPV infection

PREVENTION OF CERVICAL CANCER

Estimated New Cancers Cases 2003

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

Gynecologic Cytopathology: Glandular lesions

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation

What Causes Cervical Cancer? Symptoms of Cervical Cancer

Colposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK

Gynaecological Malignancies

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

Should Anal Pap Smears Be a Standard of Care in HIV Management?

CPC on Cervical Pathology

Thin HSIL of the Cervix: Detecting a Variant of High-grade Squamous Intraepithelial Lesions With a p16 INK4a Antibody

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

Gynecological Cancers

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy

Management that provides continuity of care for women

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

Index. Cytoplasm, nonepithelial malignant tumor features 70

Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear

Managament of Abnormal Cervical Cytology and Histology

4 Mousa Al-abbadi. Ola Al-juneidi. Abdul-rahman Ibrahim

Int. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)

Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University

HPV: cytology and molecular testing

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Cytyc Corporation - Case Presentation Archive - July 2002

BRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)

Vaginal intraepithelial neoplasia

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

National Cervical Screening Program MBS Item Descriptors

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22

The concept that invasive squamous cell carcinoma of

Gynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1

Human Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita

Cervical cancer control in developing countries

Transcription:

PATHOLOGY OF THE UTERINE CERVIX SUMALEE SIRIAUNGKUL, M.D. DEPARTMENT OF PATHOLOGY

PATHOLOGY OF THE UTERINE CERVIX Anatomy and physiology Benign diseases 1. Infections 2. Benign tumors and tumor-like lesions Premalignant lesions Malignant tumors

Endometrium Myometrium

UTERINE CERVIX Lower part of the uterus Exocervix and Endocervix Stratified nonkeratinizing squamous epithelium and Simple columnar mucin-secreting epithlium Fibrous,muscular and elastic tissue

Exocervix

Endocervix

Endocervix

Location of squamocolumnar junction in relation to the external os varies depending upon age, menstrual status, pregnancy and oral contraceptive use Ectropion = eversion of the columnar epithelium onto the ectocervix, when the cervix grows rapidly and enlarges under the influence of estrogen, after menarche and during pregnancy

Squamous metaplasia = physiological replacement of the everted columnar epithelium on the ectocervix by a newly formed squamous epithelium from the subcolumnar reserve cells. Transformation zone = region of the cervix where squamous metaplasia occurs Identifying the transformation zone is of great importance in colposcopy, as almost all manifestations of cervical neoplasia occur in this zone.

Squamocolumnar junction (SCJ) The point where the squamous epithelium meets the columnar epithelium 11

Location of the squamocolumnar junction and transformation zone 12 (a) Before menarche (b) After puberty / early reproductive age

(c) women in her 30s 13 (d) Perimenopausal (e) Post-menopausal

Transformation zone 14

Normal cervix

Cervical ectopion

Diseases of The Uterine Cervix Infections : Bacterias, Viruses ( HPV, HSV ), Others Benign Tumors and Tumor-like Lesions : Polyp / Microglandular Hyperplasia : Leiomyoma Premalignant and Malignant Lesions

Classification of HPVs Low risk HPV HPV types: 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81 High risk HPV HPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82 Baseman and Koutsky JCV 32S, 2005, S16-S24 REVIEW

Human Papillomavirus 72 Capsomers HPV Particle HPV Genome L1 protein ----> HPV genotyping -----> Prophylactic HPV vaccine

The Relationship HPV is An Infection Lesion is A Disease No HPV No Cervical Cancer

How does HPV cause cervical precancer & cancer? Persistent infections with high-risk HPV types Schiller, J. T. (2010). "Current understanding of the mechanism of HPV infection". Gynecologic Oncology 118 (1 Suppl): S12. doi:10.1016/j.ygyno.2010.04.004

Premalignant Lesions Squamous lesion 1. Dysplasia- Carcinoma in situ ( CIS ) (mild / moderate / severe) - CIS 2. Cervical Intraepithelial Neoplasia ( CIN ) (CIN 1 / CIN 2 / CIN 3) 3. Squamous Intraepithelial Lesion ( SIL ) (Low- / High- grade SIL) Adenocarcinoma in situ ( AIS )

* Classification of Precancerous Lesions * Dysplasia System CIN System Bethesda System Mild Moderate Severe CIS CA CIN 1 CIN 2 CIN 3 CA LSIL HSIL CA

Host factors Environmental factors The three steps of cervical carcinogenesis 1 2 3 26

Disease progression Time Months Years Normal epithelium HPV infection; koilocytosis CIN I CIN II CIN III Carcinoma Screening Treatment Low-grade squamous intraepithelial lesions (LSILs) High-grade squamous intraepithelial lesions (HSILs)

Squamous Intraepithelial Lesions The Bethesda System ( TBS ) Current concepts of pathogenesis and clinical behavior Two grades : Low- grade SIL / low-risk HPV / Follow : High-grade SIL / high-risk HPV / Treat Use for both cytologic ( Pap Smear) and histologic diagnosis

Criteria for Grading SIL Degree of nuclear abnormality Location of mitotic figures and undifferentiated cells Abnormal mitotic figures Koilocytes

CONDYLOMA ( LSIL ) HPV infection HPV 6, 11 (exophytic lesion) HPV 16,18,31,33 (flat lesion) Koilocytes frequently present Mostly diploid / polyploid No abnormal mitotic figures Undifferentiated cell / mitosis : Lower third Natural history : Spontaneous regression

High-grade SIL = Precancer High risk types of HPV (16,18,58,52,33,45,) Koilocytes - occasionally present Usually aneuploid Abnormal mitotic figures Undifferentiated cells / mitosis : upper two thirds Natural history : Persistence / Progression

Age and disease severity correlation 34.9 + 9.8 43.2 + 8.5 46.4 + 9.8 Age ( X+SD) Yrs. P <0.001, p for trend

EXOPHYTIC CONDYLOMA

Squamous Intraepithelial Lesion

LSIL

HSIL

Squamous Intraepithelial Lesions Age 36-42 years No abnormal symptoms ( Bleed / Leukorrhea ) Diagnosis1. Screening (Cytology / HPV test / VIA ) 2. Colposcopy 3. Biopsy

Screening Conventional pap smear (CP) : กรมการแพทย /สปสช Liquid-based cytology (LBC) HPV test (Hybrid Capture 2, Cervista, Cobas 4800) aged 30 years or older with HPV genotyping (HPV16/18) Tumor markers (P16 / Ki67 / DNA methylation) VIA (visual inspection aided by acetic acid) ใช ในประเทศก ำล งพ ฒนำ(เอเช ย/อ ฟร กำ) / กรมอนาม ย (อาย ไม เก น 45 / บ านไกล)

Sensitivity for Detection of HSIL & Cancer Conventional Pap 53% Liquid-based cytology (LBC) 74% HPV testing (HC 2) HPV testing + Liquid-based cytology 96-99% 100%*** 10 %Sensitivity for CIN2+ 20 30 40 50 60 70 80 90 100 ***Negative predictive value ~ 99-100% Ref: 1. Clavel C, e tal. BJC 2001;89:616. 2. Cuzick J, e tal. IJC 2006;119:1095. 3. Ronco G, et al. JNCI 2006;98:765

PAP Smaer

Comparison between LBC and Conventional Pap LBC

Plastic spatula Cytobrush / Bloom

LBC

Fixation for cytologic smear 95% alcohol

Pap LBC ASC LSIL HSIL

NORMAL

LSIL

HSIL

Colposcope

Adenocarcinoma In Situ (AIS) Precursor of invasive adenocarcinoma Asssociated with SIL (30-60 % of cases) Invasive carcinoma must be excluded by deep CONE biopsy (Conization)

Before fixation in formalin 1.Insert forceps in the os gently 2.Cut through 12 o clock or other 3.Avoid touching on the mucosa and lesion

Fixative for tissue specimens Formalin The best = 10% Buffered formalin Use true 10% formalin If false = Disaster How much is formalin volume? 10 x volume How fast is the penetration rate? 1 mm / hour

Microinvasive Squamous Cell Carcinoma Age 44-48 years No abnormal symptoms ( Abnormal bleed / Leukorrhea) Diagnosis 1. Screening (cytology +/- HPV test) 2. Colpolscopy 3. Definite Dx. need Conization (LEEP) / Hysterectomy

WHO 2003 A B A=Horizontal spread 7 mm B=Depth 5 mm

Measurement of invasion อพน

Invasive Squamous Cell Carcinoma (80%) Mean age 45 years ( CMU data 2556: 22-90, mean 54 ) Abnormal bleeding or Leukorrhea ( minority of asymptomatic cases) Diagnosis : Biopsy Treatment : Surgery/ Radiation / Chemotherapy

Invasive Squamous Cell Cercinoma Gross features 1. Exophytic mass 2. Ulcerative infiltrative 3. Noduloinfiltrative Histologic subtypes 1. Keratinizing SCC / Nonkeratinizing SCC 2. Well / Moderately / Poorly Differentiated SCC

Histologic Classification : WHO 2014 Epithelial Tumors Squamous cell carcinoma (75-80% / 80%) Adenocarcinoma (20-25% / 15%) Other Epithelial tumors adenosquamous carcinoma (2%) adenoid cystic adenoid basal neuroendocrine carcinoma (2%) undifferentiated

Histologic Classification : WHO 2014 Squamous tumors (Early invasive) Microinvasive SCC (MICA) or Superficially invasive SCC Squamous cell carcinoma Typical Keratinizing (well differentiated) Non-keratinizing (moderately / poorly) Variants Basaloid* Verrucous Warty Papillary Lymphoepithelioma-like Squamotransitional*

Chula/Siriraj Squamous cell carcinoma, moderately differentiated Squamous cell carcinoma, well differentiated Squamous cell carcinoma, poorly differentiated

Adenocarcinoma

* มะเร งปากมดล กในประเทศไทย : จากอด ตส ป จจ บ น * คศ./พศ. รายใหม (คน/ว น) เส ยช ว ต (คน/ว น) 2008/2551 9999 (27) 5216 (14) 2010/2553 10465 (29) 5517 (15) 2015/2558 11526 (32) 6309 (17)

*** มะเร งปากมดล กในจ งหว ดต างๆในประเทศไทย พ.ศ. 2553

*Min-Max = 17-91 years, mean= 50 yrs ผ หญ งไทยเป นมะเร งปากมดล กมากท ส ดเม ออาย เท าไร? (สถ ต ท จ งหว ดเช ยงใหม พศ 2540-2553) Age (yrs) Number % 20 3 0.04 21-30 137 1.9 31-40 1262 18.0 41-50 2562 36.3 51-60 1710 24.2 61 1375 19.5 Total 7052 100.0

Etiology and risk factors Human papillomavirus (HPV) Others

Cervical Cancer Prevention Primary prevention (Risk reduction): Avoid exposure, HPV vaccine Secondary prevention (Early detection) Screening (HPV testing, Cytology) Tertiary prevention (Treatment)

ส อประกอบการเร ยน 1. http://screening.iarc.fr (Training material) 2. Pictures of gross lesion & histopathlogy บร หารหล กส ตร http://www.med.cmu.ac.th/secret/edserv/curriculum/ 3. eslide.med.cmu.ac.th Registration : Name / Surname : email add. : Activation key repro2016

Thank You for your attention